Linklaters' Schmidt on Pfizer-Wyeth review

Linklaters' Schmidt on Pfizer-Wyeth review

The Daily Deal - 43 minutes ago
The approval by US antitrust regulators of Pfizer Inc.'s (NYSE:PFE) acquisition of Wyeth is an outlier of how merger reviews will be conducted under the Obama administration. That's according to ...